NCPA applauds FTC pick for associate director of health care
Emma Mittelstaedt Burnham is an experienced antitrust enforcer, exactly what patients and providers need to go up against PBMs and insurers.
NCPA
NCPA to CMS: Pharmacists may bail on Medicare Drug Price Negotiation Program
Cash flow problems, revenue loss would make participation untenable.
Upcoming NCPA events for pharmacy teams
Pharmacy teams can highlight their post-graduate program while connecting with students who are eager to learn more about community pharmacy.
NCPA announces finalists for 2025 Good Neighbor Pharmacy NCPA Pruitt-Schutte Student Business Plan Competition
The winning team will be announced on Sunday, Oct. 19, as part of the convention’s First General Session.
NCPA laments SCOTUS decision to punt on Oklahoma PBM reform
Court’s inaction creates confusion in the states.
Registration open for NCPA 2025 Annual Convention
The convention is set for Oct. 18-21 in New Orleans, while the pre-convention events will take place Oct. 16-17.
NCPA: Any pharma tariffs should be tailored to avoid increasing shortages and costs
NCPA is urging the Trump administration to establish certain exclusions from any tariffs, incentivize U.S. manufacturing through supportive domestic and trade policies, and reform the PBM payment model to strengthen domestic supply chains and reimburse pharmacies fairly.
Community pharmacists score hundreds of congressional visits pushing for PBM reform
Congress must act swiftly to finalize and pass robust pharmacy benefit manager reform legislation and push the Centers for Medicare & Medicaid Services to correct course on Medicare Drug Price Negotiation Program implementation.
NCPA releases new episodes of “Show Me” reality series focusing on maternal vaccines
New customizable letter also facilitates pharmacy outreach to area OB-GYNs.
NCPA urges SCOTUS to reject radical change to legal procedure that could limit class action cases
Cases against PBMs and Big Insurers could be bogged by procedural hurdles if SCOTUS sides with petitioner, NCPA says.
Senators partner on bipartisan bill to crack down on PBMs’ abusive pricing practices
Bill would protect pharmacies in Medicaid and save $2 billion over 10 years. NACDS, NCPA and FMI among groups praising the Bill.
NCPA disappointed Senate maneuver to bring up PBM reform appears stalled
"Everyone agrees this must happen, so take the win and do it. Although we are disappointed, we urge Congress to see the copious amount of bipartisan support behind this package and take it to the floor to pass without delay.”
Former NCPA president presses for PBM reform in congressional hearing
Anticompetitive PBM tactics lead to higher costs, limited choices, and pharmacy deserts.
NCPA analysis shows Medicare Drug Price Negotiation Program hurts financial stability of pharmacies
Calls for immediate freeze of Medicare Drug Price Negotiation to protect pharmacies and patients.
NCPA to CMS: A third of independent pharmacies won’t carry drugs in the Negotiated Price Program
If CMS and the new administration want to save the program, and if they want to prevent the disappearance of many more pharmacies, they will make a number of changes, said NCPA.
NCPA announces Independent Community Pharmacy Consortium for Government Engagement
New consortium unites independent pharmacies and public health agencies to enhance emergency preparedness and response.